Healx

Healx is an AI-enabled, clinical-stage biotech company focused on discovering new treatments for rare diseases. It utilizes its proprietary AI platform, Healnet, to identify and develop novel therapeutics, accelerating the drug discovery process for conditions with significant unmet needs. The company's pipeline includes programs targeting rare oncology, renal, and neurodevelopmental disorders.

Buy Funded Startups lists

Funding Round: Series C

Funding Amount: $47M

Date: 01-Aug-2024

Investors: R42 Group, Atomico, Balderton, Jonathan Milner, Global Brain, btov, Ayana Capital, o2h, VU Venture Partners

Markets: Biotechnology, AI, Rare Diseases, Artificial Intelligence (AI), Biopharma, Health Care, Life Science, Medical

HQ: Cambridge, Cambridgeshire, United Kingdom

Founded: 2014

Website: https://www.healx.ai/

LinkedIn: https://www.linkedin.com/company/healx/

Twitter: https://twitter.com/healx

Instagram: